Press Releases Recursion Pharmaceuticals, Inc.

Equities

RXRX

US75629V1044

Real-time Estimate Cboe BZX Other stock markets 02:21:54 2024-05-09 pm EDT			5-day change	1st Jan Change
8.545 ^USD	-0.52%		-2.33%	-12.93%

Apr. 18	Recursion Pharmaceuticals Insider Sold Shares Worth $367,007, According to a Recent SEC Filing	MT
Apr. 16	Recursion Pharmaceuticals Names Najat Khan Chief R&D Officer	MT

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Recursion to Report First Quarter 2024 Business Updates and Financial Results on May 9	May. 02	GL
Recursion to Report First Quarter 2024 Business Updates and Financial Results on May 9	May. 02	AQ
Recursion to Participate in Upcoming Investor Conferences	May. 01	GL
Altitude Lab Secures Small Business Administration Growth Fund Accelerator Grant to Launch Horizon, a Commercialization Partnering Program	Apr. 30	GL
Recursion Appoints Najat Khan, PhD, as Chief R&D Officer and Chief Commercial Officer	Apr. 16	GL
Recursion Appoints Najat Khan, PhD, as Chief R&D Officer and Chief Commercial Officer	Apr. 16	AQ
Recursion to Participate in Upcoming Investor Conference	Apr. 02	GL
Recursion to Participate in Upcoming Investor Conference	Apr. 02	AQ
Recursion Publishes Annual Environmental, Social and Governance Report	Mar. 26	GL
Recursion Announces Plans to Open New Office in London	Mar. 11	GL
Recursion Announces Plans to Open New Office in London	Mar. 11	AQ
Recursion Hosts Second Annual Rare Disease Day Events for Utah’s Rare Disease Community	Mar. 01	GL
Recursion Hosts Second Annual Rare Disease Day Events for Utah’s Rare Disease Community	Mar. 01	AQ
Recursion to Participate in Upcoming Investor Conferences	Mar. 01	GL
Recursion to Participate in Upcoming Investor Conferences	Mar. 01	AQ
Recursion Pharmaceuticals: Q4 Earnings Snapshot	Feb. 27	AQ
Recursion Provides Business Updates and Reports Fourth Quarter and Fiscal Year 2023 Financial Results	Feb. 27	GL
Recursion to Host Public L(earnings) Call on February 27	Feb. 20	GL
Recursion to Host Public L(earnings) Call on February 27	Feb. 20	AQ
Thinking about buying stock in BioNexus Gene Lab, Gladstone Investment Corp, Canopy Growth Corp, Recursion Pharmaceuticals, or Monolithic Power Systems?	Feb. 14	PR

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Recursion Pharmaceuticals, Inc.

Equities

RXRX

US75629V1044

Press Releases

Filters